BioVie Inc. (BIVI) Social Stream



BioVie Inc. (BIVI): $1.63

0.25 (+18.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BIVI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 474

in industry

Biovie Inc (BIVI) Price Targets From Analysts

Use the tables below to see what analysts covering Biovie Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-05-24 1 $50 $50 $50 $4.72 959.32%
2021-11-30 1 $27 $27 $27 $4.72 472.03%
2022-01-21 1 $18 $18 $18 $4.72 281.36%
2022-03-14 2 $18 $9 $13.5 $4.72 186.02%

The Trend in the Analyst Price Target


Over the past 32 weeks, BIVI's average price target has gone down $36.5.

BIVI reports an average of 297.43% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-26 0 47 47 47 21.610 117.49%
2021-06-21 1 50 50 50 16.990 194.29%
2021-08-05 1 50 50 50 13.675 265.63%
2021-08-09 1 50 50 50 9.000 455.56%
2021-11-30 1 27 27 27 6.440 319.25%

BIVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 59 days, BIVI's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Biovie Inc's number of analysts covering the stock is higher than 4.69% of them.
  • Biovie Inc's variance in analysts' estimates is lower than 20.04% of all US stocks.
  • BIVI has a higher upside potential (average analyst target price relative to current price) than 330.29% of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, Biovie Inc's average analyst price target is higher than 220.52% of them.

In the Pharmaceutical Products industry, BCYC, BCEL, and AVTE are the three stocks most similar to Biovie Inc regarding the price target and analyst recommendation information presented here.

Is BIVI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5221 seconds.